AP337A - Salts of substituted quinoline compounds and their use as inhibitors of gastric acid secretion. - Google Patents

Salts of substituted quinoline compounds and their use as inhibitors of gastric acid secretion. Download PDF

Info

Publication number
AP337A
AP337A APAP/P/1992/000352A AP9200352A AP337A AP 337 A AP337 A AP 337A AP 9200352 A AP9200352 A AP 9200352A AP 337 A AP337 A AP 337A
Authority
AP
ARIPO
Prior art keywords
salts
inhibitors
salt
gastric acid
acid secretion
Prior art date
Application number
APAP/P/1992/000352A
Other languages
English (en)
Other versions
AP9200352A0 (en
Inventor
Robert John Ife
Colin Andrew Leach
Original Assignee
Smithkline Beecham Intercredit B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919101918A external-priority patent/GB9101918D0/en
Priority claimed from GB919101919A external-priority patent/GB9101919D0/en
Application filed by Smithkline Beecham Intercredit B V filed Critical Smithkline Beecham Intercredit B V
Publication of AP9200352A0 publication Critical patent/AP9200352A0/xx
Application granted granted Critical
Publication of AP337A publication Critical patent/AP337A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)
APAP/P/1992/000352A 1991-01-29 1992-01-27 Salts of substituted quinoline compounds and their use as inhibitors of gastric acid secretion. AP337A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919101918A GB9101918D0 (en) 1991-01-29 1991-01-29 Compound
GB919101919A GB9101919D0 (en) 1991-01-29 1991-01-29 Compound

Publications (2)

Publication Number Publication Date
AP9200352A0 AP9200352A0 (en) 1992-01-31
AP337A true AP337A (en) 1994-04-08

Family

ID=26298350

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1992/000352A AP337A (en) 1991-01-29 1992-01-27 Salts of substituted quinoline compounds and their use as inhibitors of gastric acid secretion.

Country Status (18)

Country Link
EP (1) EP0569396A1 (fr)
JP (1) JPH06504541A (fr)
CN (1) CN1064268A (fr)
AP (1) AP337A (fr)
AU (1) AU652028B2 (fr)
CA (1) CA2099117A1 (fr)
CZ (1) CZ153293A3 (fr)
FI (1) FI933376A0 (fr)
HU (1) HUT67609A (fr)
IE (1) IE920267A1 (fr)
IL (1) IL100791A0 (fr)
MA (1) MA22401A1 (fr)
MX (1) MX9200338A (fr)
NO (1) NO932722L (fr)
NZ (1) NZ241408A (fr)
PT (1) PT100056A (fr)
SK (1) SK70993A3 (fr)
WO (1) WO1992012969A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9126438D0 (en) * 1991-12-12 1992-02-12 Smithkline Beecham Intercredit New quinoline derivatives
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
USRE43932E1 (en) 1997-07-18 2013-01-15 Novartis Ag Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
CA2467652A1 (fr) * 2001-11-19 2003-05-30 Altana Pharma Ag Agents utiles pour le traitement des troubles des voies aeriennes
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
EP1534278A4 (fr) 2002-08-01 2006-09-06 Nitromed Inc Inhibiteurs nitroses de la pompe a protons, compositions et procedes d'utilisation
KR20060099524A (ko) 2003-11-03 2006-09-19 아스트라제네카 아베 무증상 위식도 역류의 치료를 위한 이미다조[1,2-ａ]피리딘유도체

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0330485A1 (fr) * 1988-02-25 1989-08-30 SmithKline Beecham Intercredit B.V. Dérivés des 4-amino-3-acylquinoléines, et leur utilisation pour l'inhibition de la sécrétion gastrique

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0330485A1 (fr) * 1988-02-25 1989-08-30 SmithKline Beecham Intercredit B.V. Dérivés des 4-amino-3-acylquinoléines, et leur utilisation pour l'inhibition de la sécrétion gastrique

Also Published As

Publication number Publication date
AU652028B2 (en) 1994-08-11
MX9200338A (es) 1992-12-01
EP0569396A1 (fr) 1993-11-18
JPH06504541A (ja) 1994-05-26
CN1064268A (zh) 1992-09-09
SK70993A3 (en) 1994-01-12
NZ241408A (en) 1994-05-26
MA22401A1 (fr) 1992-10-01
PT100056A (pt) 1993-03-31
HU9302201D0 (en) 1993-10-28
NO932722D0 (no) 1993-07-28
FI933376A7 (fi) 1993-07-28
WO1992012969A1 (fr) 1992-08-06
IL100791A0 (en) 1992-09-06
IE920267A1 (en) 1992-07-29
NO932722L (no) 1993-07-28
FI933376L (fi) 1993-07-28
CA2099117A1 (fr) 1992-07-30
HUT67609A (en) 1995-04-28
AP9200352A0 (en) 1992-01-31
FI933376A0 (fi) 1993-07-28
AU1179992A (en) 1992-08-27
CZ153293A3 (en) 1993-12-15

Similar Documents

Publication Publication Date Title
JP3447292B2 (ja) イミダゾピリジン及び胃腸の疾病の治療のためのその使用
AP337A (en) Salts of substituted quinoline compounds and their use as inhibitors of gastric acid secretion.
KR100704152B1 (ko) ＮＦ-κＢ 저해제를 유효 성분으로 하는 심근염, 확장형 심근증 및 심부전의 예방제 또는 치료제
CN1127470C (zh) 新型苯并环己酮或苯并吡喃酮衍生物及其制备方法
JP2502343B2 (ja) 薬学的に活性な置換ベンズアミド
US5045541A (en) Fused pyridazine compounds and their pharmaceutical use
EP3216791B1 (fr) Substance polymorphe de chlorhydrate de yonkenafil, son procédé de préparation, composition à base de ladite substance et utilisation deladite substance
EP1097924B1 (fr) Dérivés de la 4-hydroxy-4-phenylpiperidine ayant une activité agoniste opioide et médicaments les contenant
EP0104614A1 (fr) Dérivés du phénylpipérazine et leur procédé de préparation
JP2974351B2 (ja) プロドラッグとしての６―クロロ―７，８―ジヒドロキシ―１―（４’―ヒドロキシフェニル）―２，３，４，５―テトラヒドロ―１ｈ―３―ベンズアゼピンのカルバメート
JPWO2002030896A1 (ja) ２，２−ジフェニルブタンアミド誘導体及びこれを含有する医薬
EP0146155B1 (fr) Dérivé d'un éther de n-propanolamine
WO2023154338A1 (fr) Formes solides d'un inhibiteur de parp14
JPS6130588A (ja) ベンゾ〔ｃ〕〔１，８〕ナフチリジン、その製造方法及びその使用、並びにこれらの化合物を含有する調製剤
JPH069402A (ja) 抗潰瘍剤
WO1990004590A1 (fr) Derives de benzothiadiazepine
WO2021249324A1 (fr) Composé d'alcényle pyrimidine, procédé de préparation associé et son application
CN108358856B (zh) 一种防治消化性溃疡的药物以及其制备方法和用途
JP2000038382A (ja) 新規ベンゾフラノン誘導体及びその製造方法
JPH0517442A (ja) ピペリジン誘導体
JPH01216980A (ja) アルキル―ピペラジニル―５，６―アルキレンピリミジン類
JPS60105652A (ja) Ｎ‐（４‐アセチルアミノフエナシル）アミン誘導体およびこれを含む治療用組成物ならびにこの誘導体の製造方法
HUT77949A (hu) Kinolinszármazékok, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk
WO2008010794A1 (fr) Préparations pharmaceutiques de lazabémide cristallin
HU198390B (en) Process for producing pharmaceutical compositions containing 3-carboxy-azetidine or derivatives